Page 32 - Ioscience News Today

Twist Bioscience Corporation: Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Vivlion GmbH, a company providing next-generation CRISPR gRNA libraries and screening services for the global R&D market, today announced a collaboration for the generation of gRNA libraries for CRISPR application...

Lexaria Bioscience Corp.: Lexaria Commences Human Clinical Hypertension Study TM CBDs ability to control blood pressure First of three human clinical studies hoped to validate Lexarias patented technology for hypertension relief KELOWNA, BC / ACCESSWIRE / April 22, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that its human clinical hypertension study HYPER-H21-1 is officially underway...

Queensland researchers are sampling your soil to solve deadly antibiotic resistance threat AprApril 2021 at 12:58am Sussanahs son Josh and daughter Charlie were keen to find out what was living in their soil. ( Share Print text only Nine-year-old Josh Webb has started looking at the dirt in his backyard differently.  “I thought dirt was just like nothing, it was just like a thing that someone just steps on,” Josh said. That was until Josh, with his younger sister Charlie, ...

PCG Digital: Lexaria Bioscience: Turning the Tide on Hypertension New York, New York--(Newsfile Corp. - April 15, 2021) - PCG Digital -- Hypertension, or high blood pressure, is known as the "silent killer" because it causes more than 7 million deaths each year-often with next to no symptoms. Hypertension puts people at greater risk for heart disease and stroke, the leading causes of death in the United States, according to the Centers for Disease Control. Nearly half of adults in the United S...

Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy LUND, Sweden, April 15, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to ...

TM Powers Amaris Award-Winning Products KELOWNA, BC / ACCESSWIRE / April 14, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announced that its corporate client Amari Corp.s "Everyday Calm" CBD product was named a Top CBD Product Pick by New Hope Network, host of the industry-leading Natural Products Expo conference events. Hundreds of CBD products competed to be among "New Hope Network editors To...